| Literature DB >> 35630814 |
Patrycja Grosman-Dziewiszek1, Benita Wiatrak1, Wojciech Dziewiszek1, Paulina Jawień1,2, Remigiusz Mydlikowski3, Romuald Bolejko3, Marta Szandruk-Bender1, Ewa Karuga-Kuźniewska4, Adam Szeląg1.
Abstract
(1) Background: A novel bioreactor platform of neuronal cell cultures using low-magnitude, low-frequency (LMLF) vibrational stimulation was designed to discover vibration influence and mimic the dynamic environment of the in vivo state. To better understand the impact of 40 Hz and 100 Hz vibration on cell differentiation, we join biotechnology and advanced medical technology to design the nano-vibration system. The influence of vibration on the development of nervous tissue on the selected cell line SH-SY5Y (experimental research model in Alzheimer's and Parkinson's) was investigated. (2)Entities:
Keywords: SH-SY5Y cells; cell differentiation; cell lines; low magnitude high-frequency vibration (LMHFV); neurons; vibration
Mesh:
Year: 2022 PMID: 35630814 PMCID: PMC9143216 DOI: 10.3390/molecules27103337
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
The vibration research and clinical trials.
| Vibrations | Clinical Implication | Participants |
|---|---|---|
| 100–400 Hz | Vibrotimulation—produced hearing-like sensations in the ear [ | adults and children with congenital hearing loss |
| 100 Hz localized vibration | motor recovery in neurorehabilitation [ | healthy men |
| 100 Hz vibration | flexors spasticity reduction [ | hemiplegic patients affected by upper limb spasticity |
| 40 Hz 12 weeks of vibration therapy | Parkinson’s disease [ | Adults with Parkinson’s disease |
| 40 Hz auditory stimulation | Alzheimer’s disease [ | Alzheimer’s disease mouse models |
| 20-Hz to 40-Hz vertical vibration | increased | women |
| 40 Hz acoustic stimulation | Alzheimer’s disease [ | Alzheimer’s disease mouse models |
| 40 Hz transcranial ultrasound | Alzheimer’s disease [ | Alzheimer’s disease mouse models |
| 40 Hz sound stimulation | Alzheimer’s disease [ | persons with mild and moderate Alzheimer’s disease |
| 35 Hz LMHFV vibration therapy | hip fracture healing [ | Elderly males or females aged 65 years or older with unilateral trochanteric hip fractures |
| 33 Hz vibration platform therapy | spastic cerebral palsy [ | Children with physical disabilities |
| 90 Hz low magnitude vibrations | treatment for bone fragility in children [ | children with disabling conditions |
| 12–30 Hz | optimal | pediatric cancer patients and survivors |
| 27–32 Hz vibration platform therapy | After vibration training, there was no significant difference between groups for bone resorption [ | women with breast cancer |
| 35 Hz vibration platform therapy | Enhancing bone and muscle quality [ | disabled older wheelchair users |
| 12,5 Hz whole-body vibration therapy | improves static balance in patients with fibromyalgia [ | women with fibromyalgia |
| 30 Hz vertical vibrations | prevention of postmenopausal bone loss [ | women, 3–8 years past the menopause |
| whole-body vibration (WBV) | Improved blood pressure in the hypertensive population [ | hypertensive males and females |
| Vibration frequencies of 1–8 Hz | Increase LF/HF (the relationship between sympathetic and parasympathetic nerve activities), | healthy young men |
| 8 Hz vibration belt | respiratory physiotherapy with vibration belts [ | critically ill patients with COVID-19 infection with mechanical ventilation |
| 15 Hz local vibration | plantar blood flow improvement in diabetic foot ulcers [ | diabetic and healthy adults |
Figure 1(a) The influence of the medium type and the addition of collagen on SH-SY5Y cells neurites length. Results are presented as mean values ± SD. Differences *** p < 0.001; ** p < 0.01 were deemed statistically significant. (b) The influence of vibration with frequency of 40 Hz, the medium type and the addition of collagen on SH-SY5Y cells neurites length. Results are presented as mean values ± SD. Differences *** p < 0.001; ** p < 0.01, * p < 0.05 were deemed statistically significant. (c) The influence of vibration with frequency of 100 Hz, the medium type and the addition of collagen on SH-SY5Y cells neurites length. Results are presented as mean values ± SD. Differences *** p < 0.001; ** p < 0.01, * p < 0.05 were deemed statistically significant.
Figure 2(a) The influence of the medium type and the addition of collagen on neurites density of SH-SY5Y cells. Results are presented as mean values ± SD. Differences vs. the previous day *** p < 0.001; ** p < 0.01; * p < 0.1 were deemed statistically significant. (b) The influence of vibration with frequency of 40 Hz, the medium type and the addition of collagen on neurites density of SH-SY5Y cells. Results are presented as mean values ± SD. Difference vs. the 1st day ** p < 0.01 was deemed statistically significant. (c) The influence of vibration with frequency of 100 Hz, the medium type and the addition of collagen on neurites density of SH-SY5Y cells. Results are presented as mean values ± SD. Differences vs. the previous day *** p < 0.001; ** p < 0.01 were deemed statistically significant.
Figure 3Vibration with a frequency of 40 Hz. (A) PM non-collagen—40 Hz, (B) PM non-collagen—control, (C) PM collagen—40 Hz, (D) PM collagen—control, (E) DM non-collagen—40 Hz, (F) DM non-collagen—control, (G) DM collagen—40 Hz, (H) DM collagen—control. In the upper right corner, zoom in to show neurites.
Figure 4Vibration with a frequency of 100 Hz. (A) PM non-collagen—100 Hz, (B) PM non-collagen—control, (C) PM collagen—100 Hz, (D) PM collagen—control, (E) DM non-collagen—100 Hz, (F) DM non-collagen—control, (G) DM collagen—100 Hz, (H) DM collagen—control. In the upper right corner, zoom in to show neurites.
Figure 5Expression of NeuN after 5 days of treating with frequencies (A,B) 40 Hz and (C,D) 100 Hz; (A,C) non-collagen; (B,D) collagen.
Figure 6Block diagram of the medical experiment carried out.
Figure 7(a) Laboratory stands for the generation and measurement of nanoscale vibrations. 1—computer, 2—vibrometer, 3—DDS sine wave generator, 4—incubator, 5—laser vibration detector, 6—plexiglass enclosure, 7—24 cell-culturing plate, 8—low-frequency loudspeaker. (b) Cells were placed on a probe with a tripod in the CO2 incubator.
Figure 8Distribution of vibrations of individual cells of the plate for f = 100 Hz; (a)—vibration amplitude of plate cells [nm], (b)—acceleration of plate cells [mm/s2].
Figure 9Density and lengths of neurites measurement. The length of neurites is marked with a black line, while the number is marked with arrows.